ORS 689.813: Exemption from drug labeling requirements.

(1) A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Drug Administration for the reversal of an opioid overdose if the drug is: (a) In the form of a nasal spray; and (b) Personally dispensed by a health care provider described in this subsection at the location of practice of the health care provider. (2) The information described in subsection (1) of this section includes: (a) The name of the patient; (b) The name and address of the dispensing health care provider; (c) The date of dispensing; (d)(A) The name of the drug or, if the dispensed drug does not have a brand name, the generic name of the drug along with the name of the drug distributor or manufacturer; (B) The drug’s quantity per unit, unless the drug is a compound; and (C) The directions for the drug’s use stated in the prescription; (e) Cautionary statements, if any, as required by law; and (f) When applicable and as determined by the State Board of Pharmacy, an expiration date after which the patient should not use the drug. [2023 c.285 §2]